EYET: Lots of controversy surrounding this one. Took a huge hit, but: 14:30 EYET Eyetech Pharma extends to highs of day amid talk PFE may participate in tomorrow's conference call... no confirmation (14.72 +1.77) If true, this should give the stock a boost. PFE obviously is hanging in at this point.